ZAMP Bionews

Owing to the novel properties of carbon nanotubes (CBNs), a series of problems associated with in vitro toxicity assessments of carbon nanotubes (CNTs) have appeared in many literatures. In order to properly evaluate the potential risk to human health, the cell toxicity assay of CBNs can not be conducted by traditional methods employed in common [...]

Akorn, Inc. (NASDAQ: AKRX) provided the following response regarding FDA’s draft guidance on vancomycin hydrochloride (HCl) capsules.
The Food and Drug Administration (FDA) has posted draft guidance for establishing bioequivalence (BE) for vancomycin HCl capsules. Under the guidance, the FDA is currently recommending in vitro dissolution studies only for test formulations that are qualitatively and quantitatively [...]

Absorption Systems, LP, announced that results of a recent investigation of interactions between drugs using Absorption Systems’ CellPort Technologies™ were presented by AstraZeneca at the International Society for the Study of Xenobiotics (ISSX) Meeting, which was held recently in San Diego. The results demonstrate that CellPort Technologies can help predict the potential for pharmacokinetic [...]

MatTek Corporation announced that the ECVAM Scientific Advisory Committee (ESAC) endorsed the scientific validity of the Modified EpiDerm Skin Irritation Test (SIT) at its November meeting. ESAC concluded that the Modified EpiDerm SIT has sufficient accuracy and reliability for the prediction of skin irritating and non-irritating test substances.

Tags: 60 minutes, 7th [...]

The effectiveness of voriconazole in combating fungal infections has been confirmed by a new study to be featured in the International Journal of Antimicrobial Agents (http://www.elsevier.com/locate/ijaa), published by Elsevier. Fungal infections can kill people with weakened immune systems, which can be caused by AIDS, cancer treatment or organ replacement, and the research reinforces earlier findings [...]